Cargando…
Clinico-radiologic features and therapeutic strategies in tumefactive demyelination: a retrospective analysis of 50 consecutive cases
AIMS: Our goal was to expand the spectrum of clinico-radiologic characteristics and the possible therapeutic choices in patients with tumefactive demyelinating lesions (TDLs). METHODS: A retrospective analysis of 50 patients with at least one TDL was performed at an academic neurology center (2008–2...
Autores principales: | Vakrakou, Aigli G., Tzanetakos, Dimitrios, Evangelopoulos, Maria-Eleptheria, Argyrakos, Theodore, Tzartos, John S., Anagnostouli, Maria, Andreadou, Elissavet, Koutsis, Georgios, Velonakis, Georgios, Toulas, Panagiotis, Gialafos, Elias, Dimitrakopoulos, Antonios, Psimenou, Erasmia, Stefanis, Leonidas, Kilidireas, Constantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135218/ https://www.ncbi.nlm.nih.gov/pubmed/34046086 http://dx.doi.org/10.1177/17562864211006503 |
Ejemplares similares
-
Recurrent Fulminant Tumefactive Demyelination With Marburg-Like Features and Atypical Presentation: Therapeutic Dilemmas and Review of Literature
por: Vakrakou, Aigli G., et al.
Publicado: (2020) -
Thyroid Autoimmunity Following Alemtuzumab Treatment in Multiple Sclerosis Patients
por: Kazakou, Paraskevi, et al.
Publicado: (2021) -
Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases
por: Vakrakou, Aigli G., et al.
Publicado: (2022) -
Autoimmune hemolytic anemia, demyelinating relapse, and AQP1 antibodies after alemtuzumab infusion
por: Tzartos, John S., et al.
Publicado: (2020) -
Heterogeneity of Baló’s concentric sclerosis: a study of eight cases with different therapeutic concepts
por: Tzanetakos, D., et al.
Publicado: (2020)